Advanced search
Publication Cover
Leukemia & Lymphoma Volume 42, 2001 - Issue 6
Submit an article Journal homepage
39
Views
26
CrossRef citations to date
0
Altmetric
CaseReport Article

Monotherapy with Rituximab Induces Rapid Remission of Recurrent Cold Agglutinin-Mediated Hemolytic Anemia in a Patient with Indolent Lympho-Plasmacytic Lymphoma

Yossi Cohen Departments of Hematology, Hadassah University Hospital, Jerusalem, Israel
,
Aaron Polliack Departments of Hematology, Hadassah University Hospital, Jerusalem, Israel
,
Orly Zelig Blood Bank, Hadassah University Hospital, Jerusalem, Israel
&
Ada Goldfarb Departments of Hematology, Hadassah University Hospital, Jerusalem, Israel
Pages 1405-1408 | Published online: 01 Jul 2009

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Raffaella Rossio, Ramona Cassin, Anna Lecchi, Silvia La Marca, Eti Alessandra Femia, Cristina Novembrino, Simona M. Siboni, Alessandro Noto, Gianluigi Reda & Flora Peyvandi. (2022) Acquired hemophilia A and delta storage pool deficiency in a patient with indolent non-Hodgkin lymphoma. Platelets 33:1, pages 168-170.
Read now

Articles from other publishers (25)

Juan Carlos Caballero, Elham Askari, Nerea Carrasco, Miguel Angel Piris, Begoña Perez de Camino, Laura Pardo, Javier Cornago, Jose Luis Lopez-Lorenzo, Pilar Llamas & Laura Solan. (2023) Invasive Cutaneous Candidiasis, Autoimmune Hemolytic Anemia and Pancytopenia: A Challenging Scenario for Waldenström Macroglobulinemia in an Elderly Patient. Biomedicines 11:4, pages 1007.
Crossref
Paul L. Swiecicki, Livia T. Hegerova & Morie A. Gertz. (2013) Cold agglutinin disease. Blood 122:7, pages 1114-1121.
Crossref
Roghieh Djafarzadeh, Susan Notohamiprodjo, Nicole Rieth, Monika Hofstetter, Elfriede Noessner & Peter J. Nelson. (2013) Treatment of Dermal Fibroblasts with GPI-Anchored Human TIMP-1 Protein Moderates Processes Linked to Scar Formation. Journal of Investigative Dermatology 133:3, pages 803-811.
Crossref
Sigbjørn Berentsen & Geir E. Tjønnfjord. (2012) Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Reviews 26:3, pages 107-115.
Crossref
Y. Sekkach, S. Hammi, M. Elqatni, J. Fatihi, N. Elomri, F. Mekouar, M. Badaoui, M. Jira, J. Smaali, A. El Khattabi, T. Amezyane, A. Abouzahir & D. Ghafir. (2011) Efficacité exemplaire du rituximab dans un cas d’anémie hémolytique à autoanticorps froids. Annales Pharmaceutiques Françaises 69:4, pages 205-208.
Crossref
Sigbjørn Berentsen. (2011) How I manage cold agglutinin disease. British Journal of Haematology 153:3, pages 309-317.
Crossref
Claudio Fozza & Maurizio Longinotti. (2011) Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas. Advances in Hematology 2011, pages 1-4.
Crossref
C Hu, F S Wong & L Wen. (2009) Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases. Clinical and Experimental Immunology 157:2, pages 181-190.
Crossref
Lawrence D. Petz. (2008) Cold antibody autoimmune hemolytic anemias. Blood Reviews 22:1, pages 1-15.
Crossref
M. R. Nowrousian. 2008. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology 117 148 .
Robert Eisenberg & R. John Looney. (2005) The therapeutic potential of anti-CD20. Clinical Immunology 117:3, pages 207-213.
Crossref
Leisha A. Emens, R. Todd Reilly & Elizabeth M. Jaffee. 2005. Tumor Immunology and Cancer Vaccines. Tumor Immunology and Cancer Vaccines 227 245 .
Elpis Mantadakis, Vassiliki Danilatou, Eftichia Stiakaki & Maria Kalmanti. (2004) Rituximab for refractory Evans syndrome and other immune‐mediated hematologic diseases. American Journal of Hematology 77:3, pages 303-310.
Crossref
Karl T. Hagler & James W. LynchJrJr. (2004) Paraneoplastic Manifestations of Lymphoma. Clinical Lymphoma 5:1, pages 29-36.
Crossref
Luigi Virgolini & Vanda Marzocchi. (2004) Rituximab in autoimmune diseases. Biomedicine & Pharmacotherapy 58:5, pages 299-309.
Crossref
William RastetterArturo MolinaChristine A. White. (2004) Rituximab: Expanding Role in Therapy for Lymphomas and Autoimmune Diseases. Annual Review of Medicine 55:1, pages 477-503.
Crossref
Tadeusz Robak. (2004) Monoclonal antibodies in the treatment of autoimmune cytopenias. European Journal of Haematology 72:2, pages 79-88.
Crossref
Yossi Cohen & Arnon Nagler. (2004) Treatment of refractory autoimmune diseases with ablative immunotherapy. Autoimmunity Reviews 3:2, pages 21-29.
Crossref
Lawrence D. Petz & George Garratty. 2004. Immune Hemolytic Anemias. Immune Hemolytic Anemias 401 458 .
Tait D. Shanafelt, Hans L. Madueme, Robert C. Wolf & Ayalew Tefferi. (2003) Rituximab for Immune Cytopenia in Adults: Idiopathic Thrombocytopenic Purpura, Autoimmune Hemolytic Anemia, and Evans Syndrome. Mayo Clinic Proceedings 78:11, pages 1340-1346.
Crossref
Anat Galor & Timothy O’Brien. (2018) Rituximab Treatment for Relapsed Autoimmune Hemolytic Anemia in Evans Syndrome. International Journal of Hematology 78:4, pages 335-336.
Crossref
Carsten Schröder, Agnes M. Azimzadeh, Guosheng Wu, James O. Price, James B. Atkinson & Richard N. PiersonIIIIII. (2003) Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys. Transplant Immunology 12:1, pages 19-28.
Crossref
F Camou, J.-F Viallard & J.-L Pellegrin. (2003) Intérêt du rituximab dans la maladie des agglutinines froides. La Revue de Médecine Interne 24:8, pages 501-504.
Crossref
Dhavalkumar D. Patel. (2002) B cell-ablative therapy for the treatment of autoimmune diseases. Arthritis & Rheumatism 46:8, pages 1984-1985.
Crossref
Yossi Cohen, Nael Da'as, Diana Libster, Gail Amir, Alan Berrebi & Aaron Polliack. (2002) Large‐cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine–rituximab‐containing regimens: natural history‐ or therapy‐related complication?. European Journal of Haematology 68:2, pages 80-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.